IT-12 WT1 PEPTIDE VACCINATION AGAINST GLIOMAS; COMBINATION WITH TEMOZOLOMIDE, BIOMARKERS AND IMMUNOLOGICAL RESPONSE

We report the long-term outcome on phase I study of combined WT1 peptide vaccination/temozolomide against newly diagnosed glioblastomas. Immunological biomarker and response were investigated in trials targeting newly diagnosed and recurrent cases. The survival analysis was performed on 7 patients i...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Hashimoto, Naoya, Chiba, Yasuyoshi, Kijima, Noriyuki, Arita, Hideyuki, Kinoshita, Manabu, Kagawa, Naoki, Tsuboi, Akihiro, Oka, Yoshihiro, Oji, Yusuke, Sugiyama, Haruo, Yoshimine, Toshiki
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2014
נושאים:
Abstracts
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218228/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou258.10
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים